| Schedule of Net Income (Loss) Per Share Presented in the Consolidated Statement of Operations |
The net income (loss) per share presented in the consolidated statement of operations is based on the following: | | | Three months ended June 30, 2026 | | | Three months ended June 30, 2025 | | | Net loss | | $ | (124,477 | ) | | $ | (172,412 | ) | | Less: Monthly extension fees | | | — | | | | 50,000 | | | Less: Dividend income on Trust Account to be allocated to redeemable shares | | | 1,244 | | | | 273,676 | | | Net loss excluding monthly extension fees and dividend income on Trust Account | | $ | (125,721 | ) | | $ | (496,088 | ) | | | | Six months ended June 30, 2026 | | | Six months ended June 30, 2025 | | | Net loss | | $ | (292,815 | ) | | $ | (357,450 | ) | | Less: Monthly extension fees | | | — | | | | 200,000 | | | Less: Dividend income on Trust Account to be allocated to redeemable shares | | | 2,662 | | | | 581,563 | | | Net loss excluding monthly extension fees and dividend income on Trust Account | | $ | (295,477 | ) | | $ | (1,139,013 | ) |
|
| Schedule of Basic And Diluted Net Income (Loss) Per Share |
| | | Three months ended June 30, 2026 | | | | | Redeemable shares | | | Non-redeemable shares | | | Basic and diluted net income (loss) per share: | | | | | Numerators: | | | | | | | | Allocation of net loss including accretion of temporary equity to redemption value and excluding monthly extension fees and dividend income on Trust Account | | $ | (558 | ) | | $ | (125,163 | ) | | Monthly extension fees | | | — | | | | — | | | Dividend income on Trust Account | | | 1,244 | | | | — | | | Allocation of net income (loss) | | $ | 686 | | | $ | (125,163 | ) | | | | | | | | | | | | Denominators: | | | | | | | | | | Weighted-average shares outstanding | | | 9,307 | | | | 2,086,875 | | | Basic and diluted net income (loss) per share | | $ | 0.07 | | | $ | (0.06 | ) | | | | Three months ended June 30, 2025 | | | | | Redeemable shares | | | Non-redeemable shares | | | Basic and diluted net income (loss) per share: | | | | | | | | Numerators: | | | | | | | | Allocation of net loss including accretion of temporary equity to redemption value and excluding monthly extension fees and dividend income on Trust Account | | $ | (172,583 | ) | | $ | (323,505 | ) | | Monthly extension fees | | | 50,000 | | | | — | | | Dividend income on Trust Account | | | 273,676 | | | | — | | | Allocation of net income (loss) | | $ | 151,093 | | | $ | (323,505 | ) | | | | | | | | | | | | Denominators: | | | | | | | | | | Weighted-average shares outstanding | | | 1,113,307 | | | | 2,086,875 | | | Basic and diluted net income (loss) per share | | $ | 0.14 | | | $ | (0.16 | ) | | | | Six months ended June 30, 2026 | | | | | Redeemable shares | | | Non-redeemable shares | | | Basic and diluted net income (loss) per share: | | | | | | | | Numerators: | | | | | | | | Allocation of net loss including accretion of temporary equity to redemption value and excluding monthly extension fees and dividend income on Trust Account | | $ | (1,524 | ) | | $ | (293,953 | ) | | Monthly extension fees | | | — | | | | — | | | Dividend income on Trust Account | | | 2,662 | | | | — | | | Allocation of net income (loss) | | $ | 1,138 | | | $ | (293,953 | ) | | | | | | | | | | | | Denominators: | | | | | | | | | | Weighted-average shares outstanding | | | 10,821 | | | | 2,086,875 | | | Basic and diluted net income (loss) per share | | $ | 0.11 | | | $ | (0.14 | ) | | | | Six months ended June 30, 2025 | | | | | Redeemable shares | | | Non-redeemable shares | | | Basic and diluted net income (loss) per share: | | | | | | | | Numerators: | | | | | | | | Allocation of net loss including accretion of temporary equity to redemption value and excluding monthly extension fees and dividend income on Trust Account | | $ | (525,188 | ) | | $ | (613,825 | ) | | Monthly extension fees | | | 200,000 | | | | — | | | Dividend income on Trust Account | | | 581,563 | | | | — | | | Allocation of net income (loss) | | $ | 256,375 | | | $ | (613,825 | ) | | | | | | | | | | | | Denominators: | | | | | | | | | | Weighted-average shares outstanding | | | 1,785,531 | | | | 2,086,875 | | | Basic and diluted net income (loss) per share | | $ | 0.14 | | | $ | (0.29 | ) |
|
| Schedule of Assets that are Measured at Fair Value on a Recurring Basis |
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: | Description | | Level | | | June 30, 2026 | | | December 31, 2025 | | | Assets: | | | | | | | | | | | Cash and cash equivalents held in Trust Account | | | 1 | | | $ | 103,568 | | | $ | 160,938 | |
|